Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700006 · ClinicalTrials.gov registry record
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
A clinical trial of Aging and Breast Neoplasm Female, sponsored by University of Michigan.
- Completed
- Registry status
- 94
- Enrollment target
- 1
- Study location
NCT05700006 is a study of Aging and Breast Neoplasm Female that has completed, run by University of Michigan. The registered enrollment target is 94 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05700006, a study of Aging and Breast Neoplasm Female, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot observational study is to learn about the feasibility of collecting patient-reported data and stool and blood samples from patients age 65 and older treated with aromatase inhibitor therapy for breast cancer. Participants will be treated with standard of care aromatase inhibitor therapy and will undergo serial phlebotomy, complete patient-reported questionnaires, and submit serial stool samples. The main exploratory translational questions it aims to obtain preliminary data for are: * What are the effects of aromatase inhibitor therapy on biomarkers of aging? * What are the effects of aromatase inhibitor therapy on the microbiome? These data will be used for the development of future definitive studies.
Conditions Studied
Interventions
- DRUG Aromatase inhibitor
Study Locations (1)
Michigan
- University of Michigan Rogel Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2022-07-25 |
| Est. Completion | 2026-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05700006
The ClinicalTrials.gov registry entry for NCT05700006 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Aromatase inhibitor is the first listed.
NCT05700006 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05700006 about?
NCT05700006 is a clinical study titled "Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging". The goal of this pilot observational study is to learn about the feasibility of collecting patient-reported data and stool and blood samples from patients age 65 and older treated with aromatase inhibitor therapy for breast cancer. Participants will be treated with standard of care aromatase inhibit...
What is the current status of trial NCT05700006?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2022-07-25. Estimated completion is 2026-02-26.
What conditions does trial NCT05700006 study?
This clinical trial studies the following conditions: Aging, Breast Neoplasm Female, Arthralgia.
What interventions are being tested in trial NCT05700006?
The interventions under investigation include: Aromatase inhibitor (DRUG).
Who is sponsoring clinical trial NCT05700006?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05700006 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.